PS

Parul Singh

Active Director Director DIN 09578360
DIN 09578360 First appointment Apr 2022 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value •••• Premium profile

About Parul Singh

Data last updated:

Parul Singh is a Director at Denexo Pharmaceuticals Private Limited (since 2022). The company operates in Trading. Denexo Pharmaceuticals Private Limited reported revenue of ₹42.9 Lakh (FY 2025).

DIN 09578360
Primary Designation Director
Industry Trading
First Appointment 20 Apr 2022
Oldest Company Age 4 yrs
Largest company Denexo Pharmaceuticals Private Limited · ₹42.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Apr 20222022₹42.9 Lakh (FY 2025)Active

Board colleagues of Parul Singh

NameDINCompanyDesignation
Rachit Pratap Singh08995498Denexo Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Denexo Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Parul Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Parul Singh

Parul Singh currently holds 1 directorship: Denexo Pharmaceuticals Private Limited (Director, since 20 Apr 2022, revenue ₹42.9 Lakh (FY 2025)).

Parul Singh was first appointed on 20 Apr 2022 as Director at Denexo Pharmaceuticals Private Limited.

The current boards of Parul Singh's companies include Rachit Pratap Singh (Denexo Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available